. "Indr\u00E1k, Karel" . "risk of leukaemia development; prognostic factors; blood count; myelodysplastic syndrome"@en . . . . "89" . "Indr\u00E1kov\u00E1, Jarmila" . . . "CZ - \u010Cesk\u00E1 republika" . "V\u00FDznam parametr\u016F krevn\u00EDho obrazu pro diagnostiku a odhad progn\u00F3zy u pacient\u016F s myelodysplastick\u00FDm syndromem" . "Myelodysplastick\u00FD syndrom (MDS) je zp\u016Fsoben klon\u00E1ln\u00ED poruchou krvetvorby s dysplastickou kostn\u00ED d\u0159en\u00ED. Projevuje se mono-, bi- nebo pancytopeni\u00ED v perifern\u00ED krvi a posl\u00E9ze m\u016F\u017Ee akcelerovat v akutn\u00ED leuk\u00E9mii (AL). D\u016Fle\u017Eit\u00FDm prvotn\u00EDm vy\u0161et\u0159en\u00EDm, kter\u00E9 umo\u017E\u0148uje vyslovit podez\u0159en\u00ED na MDS a p\u0159isp\u00EDv\u00E1 k diferenci\u00E1ln\u00ED diagnostice tohoto syndromu, je krevn\u00ED obraz (KO), na jeho\u017E z\u00E1klad\u011B jsou indikov\u00E1na dal\u0161\u00ED speci\u00E1ln\u00ED vy\u0161et\u0159en\u00ED k potvrzen\u00ED diagn\u00F3zy MDS. Pe\u010Dliv\u00E9 zhodnocen\u00ED v\u0161ech parametr\u016F KO v\u0161ak m\u016F\u017Ee p\u0159isp\u011Bt i k rychl\u00E9mu odhadu progn\u00F3zy nemocn\u00E9ho s MDS." . "Vondr\u00E1kov\u00E1, Jana" . . "Importance of blood count for diagnosis and prognosis in patients with myelodysplastic syndrome"@en . "351479" . . . "Zapletalov\u00E1, Jana" . "Myelodysplastick\u00FD syndrom (MDS) je zp\u016Fsoben klon\u00E1ln\u00ED poruchou krvetvorby s dysplastickou kostn\u00ED d\u0159en\u00ED. Projevuje se mono-, bi- nebo pancytopeni\u00ED v perifern\u00ED krvi a posl\u00E9ze m\u016F\u017Ee akcelerovat v akutn\u00ED leuk\u00E9mii (AL). D\u016Fle\u017Eit\u00FDm prvotn\u00EDm vy\u0161et\u0159en\u00EDm, kter\u00E9 umo\u017E\u0148uje vyslovit podez\u0159en\u00ED na MDS a p\u0159isp\u00EDv\u00E1 k diferenci\u00E1ln\u00ED diagnostice tohoto syndromu, je krevn\u00ED obraz (KO), na jeho\u017E z\u00E1klad\u011B jsou indikov\u00E1na dal\u0161\u00ED speci\u00E1ln\u00ED vy\u0161et\u0159en\u00ED k potvrzen\u00ED diagn\u00F3zy MDS. Pe\u010Dliv\u00E9 zhodnocen\u00ED v\u0161ech parametr\u016F KO v\u0161ak m\u016F\u017Ee p\u0159isp\u011Bt i k rychl\u00E9mu odhadu progn\u00F3zy nemocn\u00E9ho s MDS."@cs . "RIV/61989592:15110/09:10224433!RIV12-MSM-15110___" . "4"^^ . . "RIV/61989592:15110/09:10224433" . . "Praktick\u00FD l\u00E9ka\u0159" . . "5"^^ . . "V\u00FDznam parametr\u016F krevn\u00EDho obrazu pro diagnostiku a odhad progn\u00F3zy u pacient\u016F s myelodysplastick\u00FDm syndromem"@cs . "4"^^ . "[A3738B8133E9]" . "V\u00FDznam parametr\u016F krevn\u00EDho obrazu pro diagnostiku a odhad progn\u00F3zy u pacient\u016F s myelodysplastick\u00FDm syndromem" . . "Importance of blood count for diagnosis and prognosis in patients with myelodysplastic syndrome"@en . . "15110" . "Myelodysplastic syndrome (MDS) is a clonal haematopoietic disorder characterised by dysplastic bone marrow. It manifests as mono-, bi or pancytopenia in peripheral blood and eventually can progressto leukaemia. The first important laboratory assessment on suspicion of MDS, to enable the differential diagnosis of this syndrome is full blood count (CBC, based on which other specialised tests are indicated to confirm diagnosis of MDS. The careful evaluation of all parameters of blood count can contribute to rapid estimation of MDS prognosis."@en . "I" . "6" . "0032-6739" . . . . "V\u00FDznam parametr\u016F krevn\u00EDho obrazu pro diagnostiku a odhad progn\u00F3zy u pacient\u016F s myelodysplastick\u00FDm syndromem"@cs .